Fox Hill Wealth Management »

Biomarin Pharma Inc convertible/ shares owned by Fox Hill Wealth Management

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Fox Hill Wealth Management from 13F filings

Historical chart of Fox Hill Wealth Management investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Fox Hill Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Fox Hill Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $11k 11k 0.98

More positions owned by Fox Hill Wealth Management

Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Costco Wholesale Corporation (COST)
Adobe Systems Incorporated (ADBE)
Amazon (AMZN)
Meta Platforms Cl A (META)
Novo-nordisk A S Adr (NVO)
Spdr Gold Tr Gold Shs (GLD)
Crowdstrike Hldgs Cl A (CRWD)
Norfolk Southern (NSC)
Netflix (NFLX)
Arista Networks (ANET)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Fox Hill Wealth Management

Top funds holding Biomarin Pharma Inc convertible/

OZ Management
Millennium Management
Citigroup
Aviva
Two Sigma Investments
Calamos Advisors
Partner Fund Management
Bank of America Corporation
Lord, Abbett & Co
Sunrise Partners Limited Partnership
Centiva Capital
Jpmorgan Chase & Co
RWC Asset Management
MacKay Shields
Palisade Capital Management

View all funds holding Biomarin Pharma Inc convertible/